ANNX
Annexon, Inc.
Annexon, Inc. insider trading
Insiders at Annexon, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Love Douglas (President And CEO · Director) buying $99.8K of ANNX, filed Sep 25, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $99.8K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 24, 2026
From SEC filings · last 30 days
Recent ANNX insider transactions
Love DouglasPresident And CEO · Director
Bought 26,065 sh at $3.83 · Sep 24, 2026
$99.8K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
ANNX insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 9 insiders traded ANNX on the open market: 22 purchases worth $12.4M and 30 sales worth $635.5K, 5 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 16 purchases ($12.3M) and 13 sales ($321.4K), by 8 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$3.4M3 buys | — | |
| Q1 2026 | +$45.4K1 buy | −$313.4K10 sales | |
| Q4 2025 | +$8.8M9 buys | — | |
| Q3 2025 | +$31.2K3 buys | −$8K3 sales | |
| Q2 2025 | +$10.1K1 buy | — | |
| Q1 2025 | — | −$126.4K9 sales | |
| Q4 2024 | +$36.2K2 buys | −$40.1K1 sale · all on a plan | |
| Q3 2024 | +$53.5K3 buys | −$147.6K7 sales · 4 on a plan |
- Largest purchase
- +$3.3M of ANNX by Satter Muneer A (Director) on May 28, 2026.
- Largest sale
- −$40.1K of ANNX by Yednock Ted (EVP & Chief Innovation Officer) on Feb 18, 2026.
Open-market transactions through Jun 30, 2026most recent first
Satter Muneer A
Director
+$3.3M
May 28, 2026
613,497 sh · $5.41
Carson William H.10b5-1
Director
+$46.2K
May 11, 2026
8,000 sh · $5.78
Carson William H.10b5-1
Director
+$49.6K
Apr 10, 2026
8,000 sh · $6.20
Carson William H.10b5-1
Director
+$45.4K
Mar 10, 2026
8,000 sh · $5.67
Artis Dean Richard
EVP & Chief Scientific Officer
−$32K
Mar 02, 2026
5,894 sh · $5.43
Dananberg Jamie
Chief Medical Officer
−$31.6K
Mar 02, 2026
5,820 sh · $5.43
Yednock Ted
EVP & Chief Innovation Officer
−$30.2K
Mar 02, 2026
5,566 sh · $5.42
Lew Jennifer
EVP & Chief Financial Officer
−$30.2K
Mar 02, 2026
5,565 sh · $5.42
Overdorf Michael
EVP & Chief Business Officer
−$23.5K
Mar 02, 2026
4,339 sh · $5.42
Yednock Ted
EVP & Chief Innovation Officer
−$40.1K
Feb 18, 2026
7,857 sh · $5.11
Lew Jennifer
EVP & Chief Financial Officer
−$40.1K
Feb 18, 2026
7,851 sh · $5.11
Overdorf Michael
EVP & Chief Business Officer
−$31.7K
Feb 18, 2026
6,225 sh · $5.10
Artis Dean Richard
EVP & Chief Scientific Officer
−$27K
Feb 18, 2026
5,290 sh · $5.10
Dananberg Jamie
Chief Medical Officer
−$27K
Feb 18, 2026
5,290 sh · $5.10
Carson William H.10b5-1
Director
+$20.7K
Dec 30, 2025
4,115 sh · $5.02
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 28, 2026 | Satter Muneer ADirector | 613,497 | $5.41 | +$3.3M |
| May 11, 2026 | Carson William H.10b5-1Director | 8,000 | $5.78 | +$46.2K |
| Apr 10, 2026 | Carson William H.10b5-1Director | 8,000 | $6.20 | +$49.6K |
| Mar 10, 2026 | Carson William H.10b5-1Director | 8,000 | $5.67 | +$45.4K |
| Mar 02, 2026 | Artis Dean RichardEVP & Chief Scientific Officer | 5,894 | $5.43 | −$32K |
| Mar 02, 2026 | Dananberg JamieChief Medical Officer | 5,820 | $5.43 | −$31.6K |
| Mar 02, 2026 | Yednock TedEVP & Chief Innovation Officer | 5,566 | $5.42 | −$30.2K |
| Mar 02, 2026 | Lew JenniferEVP & Chief Financial Officer | 5,565 | $5.42 | −$30.2K |
| Mar 02, 2026 | Overdorf MichaelEVP & Chief Business Officer | 4,339 | $5.42 | −$23.5K |
| Feb 18, 2026 | Yednock TedEVP & Chief Innovation Officer | 7,857 | $5.11 | −$40.1K |
| Feb 18, 2026 | Lew JenniferEVP & Chief Financial Officer | 7,851 | $5.11 | −$40.1K |
| Feb 18, 2026 | Overdorf MichaelEVP & Chief Business Officer | 6,225 | $5.10 | −$31.7K |
| Feb 18, 2026 | Artis Dean RichardEVP & Chief Scientific Officer | 5,290 | $5.10 | −$27K |
| Feb 18, 2026 | Dananberg JamieChief Medical Officer | 5,290 | $5.10 | −$27K |
| Dec 30, 2025 | Carson William H.10b5-1Director | 4,115 | $5.02 | +$20.7K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check ANNX — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Annexon, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are ANNX insiders buying or selling?
- Between Sep 24, 2026 and Sep 24, 2026, 1 Annexon, Inc. insider made 1 open-market purchase worth $99.8K and no sales, a net purchase of $99.8K.
- How much ANNX stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 9 Annexon, Inc. insiders made 22 open-market purchases worth $12.4M and 30 sales worth $635.5K. 5 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 16 purchases ($12.3M) and 13 sales ($321.4K). The largest purchase was Satter Muneer A buying $3.3M on May 28, 2026. The largest sale was Yednock Ted selling $40.1K on Feb 18, 2026.
- What was the largest recent ANNX insider trade?
- Love Douglas (President And CEO · Director) bought $99.8K of ANNX stock on Sep 24, 2026 at about $3.83 a share.
- When did an insider last buy ANNX shares?
- The most recent open-market purchase on file is Love Douglas (President And CEO · Director) buying $99.8K on Sep 24, 2026.
- Where does ANNX insider trading data come from?
- From the Form 4 filings Annexon, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.